Oat compound shows promise for inflammation in early human trial

NCT ID NCT06101784

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested avenanthramide, a natural compound found in oats, to see if it is safe and how the body processes it. Researchers gave single and multiple doses to 92 healthy volunteers and people with low-grade inflammation. The goal was to check for side effects and measure levels of the compound in the blood, not yet to prove it reduces inflammation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

avenanthramide (an oat compound)

What this could lead to

If it works, this could point toward a natural supplement to help manage low-grade inflammation.

What could go wrong

This is a very early, first-in-human study focused on safety, not on proving the compound works. The results may not lead to any treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation inflammatory disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montreal Heart Institute

    Montreal, Quebec, H1T 1N6, Canada